Labcorp to Offer HPV and STI Self-Collection Options
Labcorp is introducing FDA-approved self-collection solutions for HPV and STI testing, offering a convenient and private option for screening.
Category: Sexually Transmitted Diseases
Sexually Transmitted Diseases
Latest
Sexually Transmitted Diseases
Latest
Emergency Department Syphilis Screening Boosts Diagnosis Rates
An emergency department dramatically increased screening and diagnosis rates for syphilis by offering optional tests for the STI.
Sexually Transmitted Diseases
Latest
FDA Grants Marketing Authorization for At-Home Syphilis Test
The FDA granted marketing authorization to NOWDiagnostics for its syphilis test, the first OTC at-home test to detect syphilis antibodies.
Testmate Health Raises $6M for At-Home STI Test
Testmate Health secured $6 million in seed funding to develop an OTC self-test for STIs, initially targeting chlamydia and gonorrhea.
Read More
CARB-X Funds Development of POC Home Test for Gonorrhea and Chlamydia
Scout received funding to develop a test to detect and differentiate between Neisseria gonorrhoeae and Chlamydia trachomatis quickly.
Read More
Is Social Stigma Hobbling Syphilis Testing?
To increase the amount of syphilis testing, labs need to remove moral judgement and acknowledge the STI as just another infection.
Read More
STI Epidemic: Lab Professionals Are Key to Stemming the Tide
To stem the tide of the STI epidemic, health care must work together through education, prevention, screening, diagnosis, and treatment.
Read More
AMA Launches Toolkit for HIV, STIs, Hepatitis, and TB Screening
Thee American Medical Association launched a new toolkit to help increase screenings for HIV, STIs, viral hepatitis and latent tuberculosis.
Read More
National Birth Defects Awareness Month Highlights Need for Increased Congenital Syphilis Testing
Emphasizing the healthcare disparities through increased testing for effective prevention of congenital syphilis needs addressing.
Read More
NOWDx Submits De Novo Classification Request to the FDA for OTC Syphilis Test
NOWDiagnostics submitted a De Novo Classification Request to the U.S. FDA for the company’s First to Know at-home syphilis test.
Read More
FDA Details Herpes Tests that May Produce False Reactive Results
The FDA is providing this information to educate health care providers and clinical laboratory staff and reduce the risk of false results.
Read More
Trinity Biotech Ships New HIV Test to Kenya
The company began commercial shipments as part of the initial purchase order for 2.5 million tests, with further shipments scheduled.
Read More
QuidelOrtho Gets FDA Clearance for Multiplex Molecular Platform and Herpes Simplex Virus Assay
QuidelOrtho received 510(K) clearance from the FDA for its innovative Savanna PCR platform and Savanna HSV 1+2/VZV in vitro diagnostic test
Read More
Why Diagnosing HIV Before Symptoms Show is Critical
HIV can hide in the body for many years before symptoms appear. Meanwhile, it is quietly killing part of the immune system.Â
Read More
FDA Grants Marketing Authorization for Chlamydia and Gonorrhea At-Home Test
The FDA granted marketing authorization to a diagnostic test for chlamydia and gonorrhea with at-home sample collection.
Read More
Ash Wellness Presents Data on STI, HIV Testing Access Barriers in Atlanta
Ash Wellness announced new community data on its StopHIVATL campaign to address the STI and HIV epidemic in Atlanta.
Read More
WHO Releases New Guidance on STI Testing, Diagnosis
The World Health Organization (WHO) shared updated guidance on testing and diagnosing sexually transmitted infections (STI).
Read More
Research Shows New Possibilities for At-Home STI Testing
Self-collected tests performed similarly to provider-collected tests for detecting common sexually transmitted infections (STIs).
Read More